GE HealthCare announces U.S. FDA 510(k) clearance and CE Mark for Allia Moveo and marks first global installation, advancing precision care in the interventional suite

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/26/2026

1. ON
2. SYNA
3. SPY
4. MU
5. VEON
6. DRI
7. NVDA
8. FDXF
9. NKE
10. AMAT

Go back to GE HealthCare announces U.S. FDA 510(k) clearance and CE Mark for Allia Moveo and marks first global installation, advancing precision care in the interventional suite

GE HealthCare (GEHC) PT Raised to $91 at BTIG

February 4, 2026 12:33 PM EST

BTIG analyst Ryan Zimmerman raised the price target on GE HealthCare (NASDAQ: GEHC) to $91.00 (from $87.00) while maintaining a Buy rating.

The analyst comments "We maintain our Buy and raise our PT to $91 (from $87) following 4Q25 results. Order growth came in at ~2.0% with a Book-to-Bill ratio of 1.06x off a more challenging... More